Results 11 to 20 of about 209,213 (308)

Occupational Interstitial Lung Diseases

open access: yesImmunology and Allergy Clinics of North America, 2023
Occupational exposures are directly causal or partially contributory to the development of interstitial lung diseases. A detailed occupational history, relevant high-resolution computed tomography findings, and where relevant additional histopathology, are required to make a diagnosis.
Hayley, Barnes, Ian, Glaspole
openaire   +7 more sources

Interstitial lung disease [PDF]

open access: yesEuropean Respiratory Review, 2014
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M.   +5 more
openaire   +4 more sources

Genetic Interstitial Lung Disease [PDF]

open access: yesClinics in Chest Medicine, 2012
The interstitial lung diseases (ILDs), or diffuse parenchymal lung diseases, are a heterogeneous collection of more than 100 different pulmonary disorders that affect the tissue and spaces surrounding the alveoli. Patients affected by ILD usually present with shortness of breath or cough; for many, there is evidence of pulmonary restriction, decreased ...
Megan Stuebner, Devine   +1 more
openaire   +2 more sources

Telomeres in Interstitial Lung Disease [PDF]

open access: yesJournal of Clinical Medicine, 2021
Interstitial lung diseases (ILD) encompass a group of conditions involving fibrosis and/or inflammation of the pulmonary parenchyma. Telomeres are repetitive DNA sequences at chromosome ends which protect against genome instability. At each cell division, telomeres shorten, but the telomerase complex partially counteracts progressive loss of telomeres ...
Stock, C, Renzoni, E
openaire   +4 more sources

Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE

open access: yesBMC Pulmonary Medicine, 2023
Background Pulmonary fibrosis (PF) is caused by a heterogeneous group of diseases, with a high inter-individual variability in disease trajectory. Identifying disease progression in patients with PF has impact on clinical management decisions.
Gizal Nakshbandi   +9 more
doaj   +1 more source

Airway involvement in interstitial lung disease [PDF]

open access: yes, 2006
PURPOSE OF REVIEW: After briefly discussing several ways to approach airway involvement in interstitial lung diseases - by diagnostic methodologies used to assess it, considering different topographical involvement, related to its presence in the diffuse
Robalo-Cordeiro, C
core   +1 more source

Interstitial lung disease: course report [PDF]

open access: yesBreathe, 2020
The @EuroRespSoc course on ILD https://bit.ly/32PtzfH.
Michael Kreuter, Vitalii Poberezhets
openaire   +2 more sources

Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review

open access: yesEuropean Respiratory Review, 2021
Over the past three decades, an increasing number of publications have reported the association between interstitial lung disease (ILD) and anti-neutrophil cytoplasmic antibody (ANCA) or ANCA-associated vasculitis (AAV). With this increased awareness, we
Suha Kadura, Ganesh Raghu
doaj   +1 more source

Smoking-related interstitial lung disease [PDF]

open access: yes, 2011
Cigarette smoking has a clear epidemiological association with lung diseases, characterised by chronic inflammation of both the bronchiolar and the interstitial lung compartments.
CERRI, Stefania   +3 more
core   +1 more source

Interstitial lung disease [PDF]

open access: yesEuropean Respiratory Review, 2013
This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
openaire   +4 more sources

Home - About - Disclaimer - Privacy